SCHEMBL26771405

SCHEMBL26771405

c1ccc2c(c1)c1ccccc1c1c3ncncc3oc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
LIMK1 P53667 1/20 0.41
ALDH1A1 P00352 7/20 0.40
PPARG P37231 2/20 0.40
NCOA1 Q15788 2/20 0.40
NCOA2 Q15596 1/20 0.40
MAPT P10636 4/20 0.39
HPGD P15428 6/20 0.38
LMNA P02545 4/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
HTT P42858 2/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 3/20 0.37
KDM4E B2RXH2 3/20 0.37
CASP3 P42574 2/20 0.37
HSD17B10 Q99714 2/20 0.37
SENP7 Q9BQF6 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28213040 0.77 KMT2A (0.43) SMN1; SMN2LIMK1ALDH1A1PPARGNCOA1
SCHEMBL22476343 0.75 AHR (0.43) SMN1; SMN2LIMK1ALDH1A1MAPTHPGD
SCHEMBL30075707 0.75 AHR (0.43) SMN1; SMN2LIMK1ALDH1A1MAPTHPGD
SCHEMBL483929 0.75 SMN1; SMN2 (0.51) SMN1; SMN2LIMK1ALDH1A1PPARGNCOA1
SCHEMBL22483141 0.74 CYP1A2 (0.42) SMN1; SMN2LIMK1ALDH1A1MAPTHPGD
SCHEMBL30356598 0.74 CYP1A2 (0.42) SMN1; SMN2LIMK1ALDH1A1MAPTHPGD
SCHEMBL21398086 0.74 CDK4 (0.42)
SCHEMBL22249679 0.73 SMN1; SMN2 (0.36) SMN1; SMN2LIMK1ALDH1A1PPARGNCOA1
SCHEMBL13509564 0.72 SMN1; SMN2 (0.38) SMN1; SMN2LIMK1ALDH1A1PPARGNCOA1
SCHEMBL21398140 0.72 SMN1; SMN2 (0.38) SMN1; SMN2LIMK1ALDH1A1PPARGNCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-23 US disclosed
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-23 US disclosed
US-20230357169-A1 ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357169-A1 ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES SLCO1B3, SLCO2B1, SLCO2A1 SMN1; SMN2 2220/4885LIMK1 504/4885ALDH1A1 389/4885
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES OR10J3, AOX1, SLCO4C1 SMN1; SMN2 3507/4885LIMK1 822/4885ALDH1A1 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.